Task: Answer the MCQ question.
Query: Which compound exhibits a -23.751% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) COc1ccccc1NC(=O)c1ccc(NS(C)(=O)=O)cc1
(b) Cc1cc(C)n(-c2ncnc3sc(C)c(C)c23)n1
(c) Clc1ccc(-n2nnnc2-c2cnc(-c3ccncc3)nc2-c2cccs2)cc1
(d) Cn1c(=O)c(C(=O)COC(=O)c2cc(-c3ccco3)nc3ccccc23)c(N)n(CC2CC2)c1=O
(e) O=S(=O)(Nc1nc2ccccc2nc1N1CCN(c2ccccc2)CC1)c1ccc(F)cc1
Answer: c. Clc1ccc(-n2nnnc2-c2cnc(-c3ccncc3)nc2-c2cccs2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Clc1ccc(-n2nnnc2-c2cnc(-c3ccncc3)nc2-c2cccs2)cc1
Clc1ccc(-n2nnnc2-c2cnc(-c3ccncc3)nc2-c2cccs2)cc1
5-[1-(4-chlorophenyl)tetrazol-5-yl]-2-pyridin-4-yl-4-thiophen-2-ylpyrimidine